An update of luteal phase support in stimulated IVF cycles (Q36878307)

16 August 2017

1 reference

title

An update of luteal phase support in stimulated IVF cycles (English)

1 reference

16 August 2017

5

Devroey P

1 reference

16 August 2017

Fatemi HM

1

1 reference

16 August 2017

Popovic-Todorovic B

series ordinal

2

1 reference

16 August 2017

Papanikolaou E

series ordinal

3

1 reference

16 August 2017

Donoso P

series ordinal

4

1 reference

16 August 2017

publication date

11 July 2007

1 reference

Human Reproduction Update

16 August 2017

published in

1 reference

16 August 2017

volume

13

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

581-590

1 reference

Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix).

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Effects of vaginal progesterone administration starting on the day of oocyte retrieval on pregnancy rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Premature ovarian failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Acute eosinophilic pneumonia associated with intramuscular administration of progesterone as luteal phase support after IVF: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Uterine contractility and embryo implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Induction of Luteolysis in the Human with a Long-Acting Analog of Luteinizing Hormone-Releasing Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

A prospective randomized study comparing intramuscular progesterone and 17alpha-hydroxyprogesterone caproate in patients undergoing in vitro fertilization-embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Use of antagonists in ovarian stimulation protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Progesterone and progestins: applications in gynecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Use of third generation gonadotropin-releasing hormone antagonists in in vitro fertilization-embryo transfer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Reproductive biology and IVF: ovarian stimulation and luteal phase consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Luteal phase characteristics following GnRH antagonist or agonist treatment - a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Ascorbic acid supplement during luteal phase in IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Day 14 maternal serum progesterone levels predict pregnancy outcome in IVF/ICSI treatment cycles: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Blastocyst culture: facts and fiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Immunosuppression by corticosteroid has no effect on the pregnancy rate in routine in-vitro fertilization/embryo transfer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Luteal support in IVF using the novel vaginal progesterone gel Crinone 8%: results of an open-label trial in 1184 women from 16 US centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Evaluation of an optimal luteal phase support protocol in IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Luteal phase support using either Crinone 8% or Utrogest: results of a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Antigonadotropic and Antisteroidogenic Actions of Peroxide in Rat Granulosa Cells*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Human endometrial receptivity: gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Vitamin C--the primate fertility factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Suppression of serum levels of luteinizing hormone by short- and long-loop negative feedback in ovariectomized women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Timing luteal phase support in GnRH agonist down-regulated IVF/embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Luteal phase support in in vitro fertilization: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Progesterone supplementation during early gestations after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Assisted reproductive technology in Europe, 1998. Results generated from European registers by ESHRE. European Society of Human Reproduction and Embryology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Regulation of endometrial prostaglandin F(2alpha) synthesis during luteolysis and early pregnancy in cattle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Progesterone versus dehydrogesterone as replacement therapy in women with premature ovarian failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Luteal phase support in infertility treatment: a meta-analysis of the randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Effect of progesterone supplementation in early pregnancy on the pregnancy outcome after in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Effects of chronic opioid antagonism on gonadotrophin and ovarian sex steroid secretion during the luteal phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Progesterone supplementation during early gestation after in vitro fertilization has no effect on the delivery rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Comparative study of the efficacy and tolerability of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

GnRH antagonists in ovarian stimulation for IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Comparison between different routes of progesterone administration as luteal phase support in infertility treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

The ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Absorption and metabolism of oral progesterone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

Delaying the initiation of progesterone supplementation results in decreased pregnancy rates after in vitro fertilization: a randomized, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMM021

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMM021

1 reference

release_ulewgap2q5cypl2wblosql4s3i

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ulewgap2q5cypl2wblosql4s3i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference